RASSF2methylation is a strong prognostic marker in younger age patients with Ewing sarcoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RASSF2methylation is a strong prognostic marker in younger age patients with Ewing sarcoma
Authors
Keywords
-
Journal
Epigenetics
Volume 8, Issue 9, Pages 893-898
Publisher
Informa UK Limited
Online
2013-08-09
DOI
10.4161/epi.25617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer
- (2012) A. Dallol et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice
- (2012) Hoogeun Song et al. EMBO JOURNAL
- Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability
- (2012) S. Gharanei et al. HUMAN MOLECULAR GENETICS
- Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
- (2011) Stephen L. Lessnick et al. Annual Review of Pathology-Mechanisms of Disease
- N-terminal RASSF family
- (2011) Nicholas Underhill-Day et al. Epigenetics
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- The Ras Effector RASSF2 Controls the PAR-4 Tumor Suppressor
- (2010) Howard Donninger et al. MOLECULAR AND CELLULAR BIOLOGY
- Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
- (2010) Undraga Schagdarsurengin et al. Molecular Cancer
- The RASSF proteins in cancer; from epigenetic silencing to functional characterization
- (2009) Antje M. Richter et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- RAN GTPase Is a RASSF1A Effector Involved in Controlling Microtubule Organization
- (2009) Ashraf Dallol et al. CURRENT BIOLOGY
- Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia
- (2009) Takeshi Nagasaka et al. JNCI-Journal of the National Cancer Institute
- The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
- (2009) Luke B Hesson et al. Molecular Cancer
- RASSF2 associates with and stabilizes the proapoptotic kinase MST2
- (2009) W N Cooper et al. ONCOGENE
- Aberrant methylation and reduced expression ofRASSF1Ain Ewing sarcoma
- (2009) Smadar Avigad et al. PEDIATRIC BLOOD & CANCER
- Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma
- (2008) Takashi Imai et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started